Clinical trial
Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT
NCT00478556 · University of Alabama at Birmingham, Other · Completed
Key facts
| NCT number | NCT00478556 |
|---|---|
| Title | Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT |
| Official title | Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | GE Healthcare Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | Omnipaque, Gastroview |
| Enrollment | 300 |
| Start date | Aug 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | May 25, 2007 |
| Last update posted | Apr 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: